|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-20
|
$1,808,081
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention
|
5R01CA142879-02
|
$323,047
|
Epstein, Ervin
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
Vitamin D3 and Intestinal Tumorigenesis
|
5R21CA143570-02
|
$147,288
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri
|
5R01CA140285-02
|
$303,435
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-03
|
$2,728,080
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Vitamin D and Colorectal Cancer
|
5R01CA122299-04
|
$335,470
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Vitamin D and Breast Cancer Biomarkers
|
5R21CA137650-02
|
$300,370
|
WOOD, MARIE
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Vitamin D Analogs for Chemoprevention of Prostate CAncer
|
4R01CA095367-07
|
$374,697
|
FOSTER, BARBARA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
5R01CA131133-04
|
$229,117
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-21S1
|
$50,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-21
|
$490,679
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
|
1R01CA155301-01
|
$343,953
|
GANN, PETER
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-23
|
$2,179,856
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using Mouse Endoscopy for Evaluating Colon Cancer
|
5R01CA125691-04
|
$351,459
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urinary Estrogen Metabolites in a 2-year Soy Trial Among Premenopausal Women
|
5R03CA150041-02
|
$66,300
|
MASKARINEC, GERTRAUD
|
UNIVERSITY OF HAWAII AT MANOA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-27
|
$1,400,911
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of Texas SPORE in Lung Cancer
|
5P50CA070907-14
|
$2,185,000
|
MINNA, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S1
|
$49,474
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S2
|
$75,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S3
|
$140,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-07
|
$1,934,104
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
2P30CA134274-04
|
$1,565,163
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-16S1
|
$74,361
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-16
|
$1,249,323
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
UCLA SPORE in Prostate Cancer
|
5P50CA092131-10
|
$2,185,000
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UAB Cancer Research Experiences for Students (CaRES)
|
5R25CA076023-12
|
$319,683
|
WATERBOR, JOHN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Type II 11B-Hydroxysteroid Dehydrogenase and Colorectal Tumorigenesis
|
5R01CA122620-03
|
$313,486
|
Zhang, Mingzhi
|
VANDERBILT UNIVERSITY
|
|
Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
|
1R01CA157735-01
|
$300,212
|
Tochtrop, Gregory
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Translational Research of Finasteride and Selenium Prevention of Prostate Cancer
|
5P01CA126804-05
|
$1,057,155
|
IP, CLEMENT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Translational Research in Colon Cancer Prevention & Treatment
|
5K05CA142885-03
|
$162,001
|
SINICROPE, FRANK
|
MAYO CLINIC
|
|
Translational Research in Breast Cancer
|
5P50CA058183-17
|
$2,185,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tpl2 in Carcinogenesis-Related Inflammation
|
1UA5CA152907-01A1
|
$380,871
|
DeCicco-Skinner, Kathleen
|
AMERICAN UNIVERSITY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-28
|
$797,203
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Theranostic Nanomedicine for Breast Cancer Prevention and Image-Guided Therapy
|
5K99CA153948-02
|
$123,401
|
Rai, Prakash
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The Sphingolipid Pathway in Colon Cancer Chemoprevention
|
5R01CA124687-04
|
$301,913
|
KAWAMORI, TOSHIHIKO
|
UNIVERSITY OF HAWAII AT MANOA
|
|
The role of the mitotic spindle protein RHAMM in early stage bladder cancer
|
1F31CA153934-01A1
|
$26,245
|
Stone II, Randolph
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
|
ZIA BC 010026
|
$434,558
|
Colburn, Nancy
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|